Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions

This publication has 13 references indexed in Scilit:

• Longer Patents for Increased Generic Competition in the US
  PharmacoEconomics, 1996
• Returns to R&D on new drug introductions in the 1980s
  Journal of Health Economics, 1994
• Does expenditure on pharmaceuticals give good value for money?: current evidence and policy implications
  Health Policy, 1993
• Misoprostol
  PharmacoEconomics, 1993
• The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
  Archives of internal medicine (1960), 1993
• US Medicaid Drug Formularies
  PharmacoEconomics, 1992
• An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
  The American Journal of Cardiology, 1991
• Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management
  JAMA, 1990
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
  Archives of internal medicine (1960), 1988
• Medicaid Patients' Access To New Drugs
  Health Affairs, 1988